Fridolin Gross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fridolin Gross has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Ciliberto
Affiliations Pázmány Péter Catholic University, Faculty of Information Technology and Bionics, Budapest, Hungary, IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
2 shared publications - Dávid Szüts
Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
2 shared publications - Elena Chiroli
The IFOM, the FIRC (Fondazione Italiana per la Ricerca sul Cancro) Institute of Molecular Oncology, 20139 Milano, Italy
2 shared publications - Federica Natali
Institute of Medical Biology (IMB) Agency for Science, Technology and Research (A*STAR) Singapore Singapore
2 shared publications - Francesca Macaluso
IFOM The Firc Institute of Molecular Oncology Milano Italy
2 shared publications - Gerhard Schratt
Laboratory of Systems Neuroscience, Institute for Neuroscience, Department of Health Science and Technology, ETH Zürich, Zurich, Switzerland
2 shared publications
Latest Publications
- 17 January 2024
- Published by Springer Nature in Erkenntnis
- Vol. 90 (4) , 1583-1603
The Explanatory Role of Machine Learning in Molecular Biology
- 17 January 2024
- Published by Springer Nature in Erkenntnis
- Vol. 90 (4) , 1583-1603
The Explanatory Role of Machine Learning in Molecular Biology
- 21 February 2022
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 38 (9) , 2466-2473
scanMiR: a biochemically based toolkit for versatile and efficient microRNA target prediction
MicroRNAs are important post-transcriptional regulators of gene expression, but the identification of functionally relevant targets is still challenging. Recent research has shown improved prediction of microRNA-mediated repression using a biochemical model combined with empirically-derived k-mer affinity predictions; however, these findings are not easily applicable. We translate this approach into a flexible and user-friendly bioconductor package, scanMiR, also available through a web interface. Using lightweight linear models, scanMiR efficiently scans for binding sites, estimates their affinity and predicts aggregated transcript repression. Moreover, flexible 3′-supplementary alignment enables the prediction of unconventional interactions, such as bindings potentially leading to target-directed microRNA degradation or slicing. We showcase scanMiR through a systematic scan for such unconventional sites on neuronal transcripts, including lncRNAs and circRNAs. Finally, in addition to the main bioconductor package implementing these functions, we provide a user-friendly web application enabling the scanning of sequences, the visualization of predicted bindings and the browsing of predicted target repression. scanMiR and companion packages are implemented in R, released under the GPL-3 and accessible on Bioconductor (https://bioconductor.org/packages/release/bioc/html/scanMiR.html) as well as through a shiny web server (https://ethz-ins.org/scanMiR/). Supplementary data are available at Bioinformatics online.
- 21 February 2022
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 38 (9) , 2466-2473
scanMiR: a biochemically based toolkit for versatile and efficient microRNA target prediction
MicroRNAs are important post-transcriptional regulators of gene expression, but the identification of functionally relevant targets is still challenging. Recent research has shown improved prediction of microRNA-mediated repression using a biochemical model combined with empirically-derived k-mer affinity predictions; however, these findings are not easily applicable. We translate this approach into a flexible and user-friendly bioconductor package, scanMiR, also available through a web interface. Using lightweight linear models, scanMiR efficiently scans for binding sites, estimates their affinity and predicts aggregated transcript repression. Moreover, flexible 3′-supplementary alignment enables the prediction of unconventional interactions, such as bindings potentially leading to target-directed microRNA degradation or slicing. We showcase scanMiR through a systematic scan for such unconventional sites on neuronal transcripts, including lncRNAs and circRNAs. Finally, in addition to the main bioconductor package implementing these functions, we provide a user-friendly web application enabling the scanning of sequences, the visualization of predicted bindings and the browsing of predicted target repression. scanMiR and companion packages are implemented in R, released under the GPL-3 and accessible on Bioconductor (https://bioconductor.org/packages/release/bioc/html/scanMiR.html) as well as through a shiny web server (https://ethz-ins.org/scanMiR/). Supplementary data are available at Bioinformatics online.
- 4 October 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (22) , e108225
Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 4 October 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (22) , e108225
Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
- 29 July 2021
- Published by Springer Nature in Synthese
- Vol. 199 (5-6) , 12073-12102
Between mechanical clocks and emergent flocks: complexities in biology
Even though complexity is a concept that is ubiquitously used by biologists and philosophers of biology, it is rarely made precise. I argue that a clarification of the concept is neither trivial nor unachievable, and I propose a unifying framework based on the technical notion of “effective complexity” that allows me to do justice to conflicting intuitions about biological complexity, while taking into account several distinctions in the usage of the concept that are often overlooked. In particular, I propose a distinction between two kinds of complexity, “mechanical” and “emergent”, which can be understood as different ways of relating the effective complexity of mechanisms and of behaviors in biological explanations. I illustrate the adequacy of this framework by discussing different attempts to understand intracellular organization in terms of pathways and networks. My framework provides a different way of thinking about recent philosophical debates, for example, on the difference between mechanistic and topological explanations and about the concept of emergence. Moreover, it can contribute to a proper assessment of metascientific arguments that invoke biological complexity.
- 29 July 2021
- Published by Springer Nature in Synthese
- Vol. 199 (5-6) , 12073-12102
Open AccessBetween mechanical clocks and emergent flocks: complexities in biology
Even though complexity is a concept that is ubiquitously used by biologists and philosophers of biology, it is rarely made precise. I argue that a clarification of the concept is neither trivial nor unachievable, and I propose a unifying framework based on the technical notion of “effective complexity” that allows me to do justice to conflicting intuitions about biological complexity, while taking into account several distinctions in the usage of the concept that are often overlooked. In particular, I propose a distinction between two kinds of complexity, “mechanical” and “emergent”, which can be understood as different ways of relating the effective complexity of mechanisms and of behaviors in biological explanations. I illustrate the adequacy of this framework by discussing different attempts to understand intracellular organization in terms of pathways and networks. My framework provides a different way of thinking about recent philosophical debates, for example, on the difference between mechanistic and topological explanations and about the concept of emergence. Moreover, it can contribute to a proper assessment of metascientific arguments that invoke biological complexity.
- Open Access
scanMiR: a biochemically-based toolkit for versatile and efficient microRNA target prediction
Despite the importance of microRNAs (miRNAs) in regulating a broad variety of biological processes, accurately predicting the transcripts they repress remains a challenge. Recent research suggests improved miRNA target prediction using a biochemical model combined with empirically-derived affinity predictions across 12mer sequences. Here, we translate this approach into a generally applicable, flexible and user-friendly tool (scanMiR). By compressing and handling miRNA 12mer affinity predictions into lightweight models, scanMiR can efficiently scan for both canonical and non-canonical binding sites on transcripts and custom sequences (including circRNAs and lncRNAs). Aggregation of binding sites into predicted transcript repression using a generalized biochemical model correlates better with experimental data than the most accurate alternative publicly available predictions. Moreover, a flexible 3’-supplementary alignment enables scanMiR to highlight and visualize unconventional modes of miRNA target mRNA interactions, such as bindings leading to target-directed miRNA degradation (TDMD) and slicing. By specifically scanning for these unconventional binding sites in brain-derived expression data, we provide a first systematic overview of potential TDMD and slicing sites on brain-specific lncRNAs as well as circRNAs. Finally, in addition to the main bioconductor package implementing these functions, we provide a user-friendly web application enabling the scanning of sequences, the visualization of predicted bindings, and the browsing of predicted target repression.
Open AccessscanMiR: a biochemically-based toolkit for versatile and efficient microRNA target prediction
Despite the importance of microRNAs (miRNAs) in regulating a broad variety of biological processes, accurately predicting the transcripts they repress remains a challenge. Recent research suggests improved miRNA target prediction using a biochemical model combined with empirically-derived affinity predictions across 12mer sequences. Here, we translate this approach into a generally applicable, flexible and user-friendly tool (scanMiR). By compressing and handling miRNA 12mer affinity predictions into lightweight models, scanMiR can efficiently scan for both canonical and non-canonical binding sites on transcripts and custom sequences (including circRNAs and lncRNAs). Aggregation of binding sites into predicted transcript repression using a generalized biochemical model correlates better with experimental data than the most accurate alternative publicly available predictions. Moreover, a flexible 3’-supplementary alignment enables scanMiR to highlight and visualize unconventional modes of miRNA target mRNA interactions, such as bindings leading to target-directed miRNA degradation (TDMD) and slicing. By specifically scanning for these unconventional binding sites in brain-derived expression data, we provide a first systematic overview of potential TDMD and slicing sites on brain-specific lncRNAs as well as circRNAs. Finally, in addition to the main bioconductor package implementing these functions, we provide a user-friendly web application enabling the scanning of sequences, the visualization of predicted bindings, and the browsing of predicted target repression.
- Open Access
Epistasis, aneuploidy, and gain-of-function mutations underlie the evolution of resistance to induced microtubule depolymerization
Microtubules, polymers of alpha- and beta-tubulin, are essential cellular components. When microtubule polymerization is hindered, cells are delayed in mitosis, but eventually they manage to proliferate with massive chromosome missegregation. Several studies have analyzed the first cell division upon microtubules impairing conditions. Here, we asked how cells cope on the long term. Taking advantage of mutations in beta-tubulin, we evolved in the lab for ∼150 generations 24 populations of yeast cells unable to properly polymerize microtubules. At the end of the evolution experiment, cells re-gained the ability to form microtubules, and were less sensitive to microtubule depolymerizing drugs. Whole genome sequencing allowed us to identify genes recurrently mutated (tubulins and kinesins) as well as the pervasive duplication of chromosome VIII. We confirmed that mutations found in these genes and disomy of chromosome VIII allow cells to compensate for the original mutation in beta-tubulin. The mutations we identified were mostly gain-of-function, likely re-allowing the proper use of the mutated form of beta-tubulin. When we analyzed the temporal order of mutations leading to resistance in independent populations, we observed multiple times the same series of events: disomy of chromosome VIII followed by one additional adaptive mutation in either tubulins or kinesins. Analyzing the epistatic interactions among different mutations, we observed that some mutations benefited from the disomy of chromosome VIII and others did not. Given that tubulins are highly conserved among eukaryotes, our results are potentially relevant for understanding the emergence of resistance to drugs targeting microtubules, widely used for cancer treatment.
Open AccessEpistasis, aneuploidy, and gain-of-function mutations underlie the evolution of resistance to induced microtubule depolymerization
Microtubules, polymers of alpha- and beta-tubulin, are essential cellular components. When microtubule polymerization is hindered, cells are delayed in mitosis, but eventually they manage to proliferate with massive chromosome missegregation. Several studies have analyzed the first cell division upon microtubules impairing conditions. Here, we asked how cells cope on the long term. Taking advantage of mutations in beta-tubulin, we evolved in the lab for ∼150 generations 24 populations of yeast cells unable to properly polymerize microtubules. At the end of the evolution experiment, cells re-gained the ability to form microtubules, and were less sensitive to microtubule depolymerizing drugs. Whole genome sequencing allowed us to identify genes recurrently mutated (tubulins and kinesins) as well as the pervasive duplication of chromosome VIII. We confirmed that mutations found in these genes and disomy of chromosome VIII allow cells to compensate for the original mutation in beta-tubulin. The mutations we identified were mostly gain-of-function, likely re-allowing the proper use of the mutated form of beta-tubulin. When we analyzed the temporal order of mutations leading to resistance in independent populations, we observed multiple times the same series of events: disomy of chromosome VIII followed by one additional adaptive mutation in either tubulins or kinesins. Analyzing the epistatic interactions among different mutations, we observed that some mutations benefited from the disomy of chromosome VIII and others did not. Given that tubulins are highly conserved among eukaryotes, our results are potentially relevant for understanding the emergence of resistance to drugs targeting microtubules, widely used for cancer treatment.